+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Biopolymers for Medical Applications Market by Type (Bio-Based Polyethylene, Bio-degradable Starch Blends, Bio-PC), Source (Natural, Synthetic), Application - Forecast 2024-2030- Product Image
Global Biopolymers for Medical Applications Market by Type (Bio-Based Polyethylene, Bio-degradable Starch Blends, Bio-PC), Source (Natural, Synthetic), Application - Forecast 2024-2030- Product Image
Sale

Global Biopolymers for Medical Applications Market by Type (Bio-Based Polyethylene, Bio-degradable Starch Blends, Bio-PC), Source (Natural, Synthetic), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829857
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biopolymers for Medical Applications Market size was estimated at USD 2.43 billion in 2023, USD 3.00 billion in 2024, and is expected to grow at a CAGR of 23.24% to reach USD 10.52 billion by 2030.

Biopolymer market for medical applications is experiencing significant growth owing to the ever-evolving demands of the modern healthcare industry. These natural or biologically synthesized polymers are essential in the creation of cutting-edge medical tools and devices, including biodegradable stents, drug delivery systems, and sutures, all admired for their compatibility with the human body, natural decomposition, and reduced toxicity. Their applications are diverse, spanning regenerative medicine, pharmaceuticals, and surgical procedures. Market expansion is fueled by the surging need for biocompatible materials, groundbreaking technological progression in biopolymers, and a rising prevalence of chronic diseases.

The market teems with opportunities, promising advances in production efficiency and novel biopolymers featuring smart functional properties such as stimuli-responsiveness. Nevertheless, the industry faces certain constraints, including the steep costs of research and development, stringent regulatory landscapes, and stiff competition from synthetic polymers. Undoubtedly, innovation and research are pivotal, focusing on developing tailored biopolymers for specific medical needs and optimizing performance to align with clinical applications. Additionally, exploring sustainable production methods and forging strong relationships with healthcare entities will be instrumental in advancing this exciting field.

Regional Insights

The United States is at the forefront in the consumption and innovation of biopolymers for medical applications due to its robust medical infrastructure. The demand is driven by advanced healthcare facilities, a growing elderly population, and a strong focus on sustainable materials. Canadian efforts align with those of the US, emphasizing ecological impact and the integration of biopolymers in advanced wound care and orthopedics. In terms of latest patents, research and investment, North America is a productive ground for innovation in biopolymer technology. EU countries exhibit a robust commitment to reducing environmental impact, which translates to active support for biopolymer applications in the medical sector.

Much of the demand is influenced by the region's strong regulatory framework for medical devices and materials, particularly those that are eco-friendly and sustainable. Recent investments in the EU are funneled into research institutions focusing on biopolymers, and institutions such as the European Patent Office showcase a steady stream of new patents, indicating a dynamic innovation landscape. In Asia Pacific's biopolymer market, China, Japan, and India are prominent players. The region presents a diverse market with consumer needs varying from affordable healthcare solutions in India to advanced medical technologies in Japan.

Market Trends by Segment

  • Type: Rising inclination toward the sustainability is emphasizing focus on application of biopolymers healthcare
  • Source: Synthetic biopolymers are in demand due to enhanced biocompatibility, biofunctionality, mechanical properties, degradation rates, and immunogenicity
  • Application: Expandable use in drug discovery, and wound closure owing to the rising tissue generation capability

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

DuPont Completes Acquisition of Spectrum Plastics Group

DuPont acquired Spectrum Plastics Group, a company renowned for its expertise in the specialty medical device and component segments. The acquisition is a strategic move to amplify DuPont's growth, as it seeks to enhance its comprehensive solutions in healthcare with Spectrum's focus on burgeoning therapeutic areas such as structural heart treatments and surgical robotics. Spectrum, which boasts a robust workforce and significant annual revenue, to integrate into DuPont's Industrial Solutions within the Electronics & Industrial sector, reinforcing DuPont's commitment to the high-growth healthcare market by now constituting roughly 10 percent of its business portfolio.

Sanofi completes acquisition of Provention Bio, Inc.

Sanofi acquired of Provention Bio, Inc., marking a strategic enhancement to its General Medicines portfolio by integrating TZIELD (teplizumab-mzwv), a novel therapy with the distinction of being first-in-class for type 1 diabetes. This strategic acquisition, fueled by the recent FDA approval of TZIELD to delay stage 3 of type 1 diabetes, fortifies the company's presence in the healthcare market, particularly benefiting individuals aged 8 and above with stage 2 of the condition.

Victrex Invests In New Medical Device Product Development Centre And Manufacturing Expansion

Victrex has enhanced its commitment to driving forward medical advances through sustainable products with significant new investments in its medical division, Invibio Biomaterial Solutions. The company announced the inauguration of a state-of-the-art product development facility in Leeds, which marks the beginning of a strategic expansion aimed at propelling medical application innovations. This development complements the deep-rooted expertise at Victrex’s primary manufacturing site in Hillhouse. This initiative underscored Victrex's resolve to intertwine with academic spheres and medical industries within the UK but also hints at the potential for additional growth trajectories in the future.

Key Company Profiles

The report delves into recent significant developments in the Biopolymers for Medical Applications Market, highlighting leading vendors and their innovative profiles. These include BASF SE, Biesterfeld AG, BioPolymer GmbH & Co. KG, Blafar Ltd., Corbion NV, Danimer Scientific, Inc., DuPont de Nemours, Inc., Eastman Chemical Company, Evonik Industries AG, Geistlich Pharma AG, GELITA AG, Green Dot Bioplastics Inc., HTL, HyMedPoly, Invibio Ltd. by Victrex PLC, ITV Denkendorf Product Service GmbH, Merck & Co., Inc., NatureWorks LLC, Rodenburg Productie B.V., Solvay S.A., SolyPlus GmbH, Symatese, Tate & Lyle PLC, Thermo Fisher Scientific, Inc., and Toray Industries Inc.

This research report offers invaluable insights into various crucial aspects of the Biopolymers for Medical Applications Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Biopolymers demand for Manufacturing of Medical Devices and Implants
5.1.1.2. Growing Adoption of Biopolymers for Advanced Imaging and Skeletal Tissue-Specific Therapeutics
5.1.1.3. Development of Sterilization Technology for Biopolymers
5.1.2. Restraints
5.1.2.1. Performance Issues Associated with the Biopolymers
5.1.3. Opportunities
5.1.3.1. Innovations and Sustainable Production of Biopolymers
5.1.3.2. Proliferation of Nano-Particle Drug Delivery Systems in Cancer
5.1.4. Challenges
5.1.4.1. Biocompatibility Issues Associated with Synthetic Biopolymers
5.2. Market Segmentation Analysis
5.2.1. Type: Rising inclination toward the sustainability is emphasizing focus on application of biopolymers healthcare
5.2.2. Source: Synthetic biopolymers are in demand due to enhanced biocompatibility, biofunctionality, mechanical properties, degradation rates, and immunogenicity
5.2.3. Application: Expandable use in drug discovery, and wound closure owing to the rising tissue generation capability
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
5.9.1. Patent Analysis & Trend
6. Biopolymers for Medical Applications Market, by Type
6.1. Introduction
6.2. Bio-Based Polyethylene
6.3. Bio-degradable Starch Blends
6.4. Bio-PC
6.5. Bio-PET
6.6. Bio-PUR
6.7. Cellulose Derivatives
6.8. PHA
6.9. Regenerated Cellulose
7. Biopolymers for Medical Applications Market, by Source
7.1. Introduction
7.2. Natural
7.3. Synthetic
8. Biopolymers for Medical Applications Market, by Application
8.1. Introduction
8.2. Bioresorbable Scaffolds
8.3. Dentistry
8.4. Drug Delivery Systems.
8.5. Healing Products
8.6. Surgical Implant Devices
8.7. Therapeutic Imaging
8.8. Wound Closure
9. Americas Biopolymers for Medical Applications Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biopolymers for Medical Applications Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Biopolymers for Medical Applications Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. DuPont Completes Acquisition of Spectrum Plastics Group
12.3.2. Sanofi completes acquisition of Provention Bio, Inc.
12.3.3. Victrex Invests In New Medical Device Product Development Centre And Manufacturing Expansion
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET RESEARCH PROCESS
FIGURE 2. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET DYNAMICS
FIGURE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BASED POLYETHYLENE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BASED POLYETHYLENE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 70. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 71. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 74. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 75. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 76. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 77. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 95. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 102. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 104. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 105. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 110. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 111. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 116. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 117. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 120. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 122. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 123. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 128. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 129. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 134. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 135. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 140. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 141. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 144. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 145. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 146. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 147. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 152. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 153. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 158. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 159. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 164. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 165. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 175. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 176. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 177. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 178. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 179. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 184. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 185. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 188. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 190. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 191. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 196. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 197. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 200. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 201. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 202. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 203. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 208. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 209. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 214. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 215. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 218. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 219. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 220. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 221. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 226. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 227. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 230. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 231. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 232. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 233. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 238. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 239. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 244. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 245. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 250. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 251. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 254. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 256. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 262. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 266. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 267. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 268. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 269. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 274. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 275. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 280. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 281. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 284. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 285. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 286. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 287. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 296. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 298. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 302. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • BASF SE
  • Biesterfeld AG
  • BioPolymer GmbH & Co. KG
  • Blafar Ltd.
  • Corbion NV
  • Danimer Scientific, Inc.
  • DuPont de Nemours, Inc.
  • Eastman Chemical Company
  • Evonik Industries AG
  • Geistlich Pharma AG
  • GELITA AG
  • Green Dot Bioplastics Inc.
  • HTL
  • HyMedPoly
  • Invibio Ltd. by Victrex PLC
  • ITV Denkendorf Product Service GmbH
  • Merck & Co., Inc.
  • NatureWorks LLC
  • Rodenburg Productie B.V.
  • Solvay S.A.
  • SolyPlus GmbH
  • Symatese
  • Tate & Lyle PLC
  • Thermo Fisher Scientific, Inc.
  • Toray Industries Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.52 Billion
Compound Annual Growth Rate23.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Biopolymer Films Market by Raw Material (Bio-based, Synthetic), Product (Cellophane, Mulch films, Polyamide films), Technology, End-user - Forecast 2024-2030 - Product Image

Global Biopolymer Films Market by Raw Material (Bio-based, Synthetic), Product (Cellophane, Mulch films, Polyamide films), Technology, End-user - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Global Castor Oil-Based Biopolymer Market by Polymer Type (Bio-Polyamides, Bio-Polyurethane), Form (Pellets, Yarns), End User - Forecast 2024-2030 - Product Image

Global Castor Oil-Based Biopolymer Market by Polymer Type (Bio-Polyamides, Bio-Polyurethane), Form (Pellets, Yarns), End User - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Global Biopolymers Market Size, Share & Trends Analysis Report By End-use), By Application, By Product (Biodegradable Polyesters, Bio-PE, Bio-PET, Polylactic Acid (PLA), Polyhydroxyalkanoate (PHA), and Others), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Biopolymers Market Size, Share & Trends Analysis Report By End-use), By Application, By Product (Biodegradable Polyesters, Bio-PE, Bio-PET, Polylactic Acid (PLA), Polyhydroxyalkanoate (PHA), and Others), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Bioplastics and Biopolymers Market Forecast to 2030 - Global Analysis by Product Type; End Use Industry - Product Image

Bioplastics and Biopolymers Market Forecast to 2030 - Global Analysis by Product Type; End Use Industry

  • Report
  • 232 Pages
  • Global
From
Biopolymer Film Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Biopolymer Film Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 93 Pages
  • Global
From

About the Medical Biopolymer Market

Medical biopolymers are bioplastics used in the medical industry. They are biodegradable, biocompatible, and non-toxic materials that can be used in a variety of medical applications, such as implants, prosthetics, and drug delivery systems. Medical biopolymers are typically derived from renewable sources, such as corn, sugarcane, and other plant-based materials. They are also often used in combination with other materials, such as metals, ceramics, and polymers, to create more complex medical devices. Medical biopolymers offer a number of advantages over traditional materials, such as improved biocompatibility, reduced risk of infection, and improved durability. They are also more cost-effective than traditional materials, making them attractive to medical device manufacturers. Some of the major companies in the medical biopolymer market include BASF, DowDuPont, Corbion, NatureWorks, and Novamont. These companies produce a variety of biopolymers for medical applications, including polylactic acid, polyhydroxyalkanoates, and polycaprolactone. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.